skip to main content


Sep 16, 2015

Actavis Pharma Company v. Alcon Canada Inc.

Featuring: Peter Wilcox and Marian Wolanski

We successfully represented Alcon and Bayer in this appeal brought by Actavis. The Federal Court had upheld the validity of Bayer’s patent relating to the antibiotic moxifloxacin, the active ingredient in Alcon’s VIGAMOX product. On appeal, the Federal Court of Appeal confirmed the validity of the patent.


  • Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy